Wang Yuan-yu, Ye Zai-yuan, Zhao Zhong-sheng, Tao Hou-quan
Department of General Surgery, Zhejiang Provincial People's Hospital, Hangzhou 310014, China.
Zhonghua Wei Chang Wai Ke Za Zhi. 2007 May;10(3):269-73.
To investigate the relationship between the expression of vascular endothelial growth factor (VEGF) and fms-like tyrosine kinase (Flt-1) mRNA and tumor progression, microvessel density and survival time in gastric carcinoma.
In situ hybridization and immunohistochemical techniques were used to detect the gene expression of VEGF, Flt-1 and CD34 in 118 gastric carcinoma specimens.
In situ hybridization revealed that positive expression rates of VEGF and Flt-1 mRNA in gastric carcinoma were 54.24% and 55.9% respectively. There was a significant correlation between the expression of VEGF and Flt-1 mRNA and growth pattern, the depth of tumor invasion, vessel invasion, lymph node and distant metastasis (P < 0.01). The mean tumor microvessel densities (MVD) in patients of stage T3-T4 or those with vessel invasion, lymph node and distant metastases were significantly higher than those of stage T1-T2 and without metastases (P < 0.01). MVD value was correlated with the expression levels of VEGF and Flt-1 mRNA (P < 0.01). The mean survival time and survival rate of patients with positive mRNA expression and mean MVD value >or=54.9/mm2 were significantly lower than those of patients with negative mRNA expression and mean MVD value < 54.9/mm2.
The expression of VEGF and Flt-1 can promote tumor angiogenesis and contribute to tumor invasion and metastasis in gastric carcinoma. VEGF and Flt-1 may serve as valuable indicators of biological behaviour, prognosis and target of gene therapy in gastric carcinoma.
探讨血管内皮生长因子(VEGF)和fms样酪氨酸激酶(Flt-1)mRNA表达与胃癌肿瘤进展、微血管密度及生存时间的关系。
采用原位杂交和免疫组化技术检测118例胃癌标本中VEGF、Flt-1和CD34的基因表达。
原位杂交显示,胃癌中VEGF和Flt-1 mRNA的阳性表达率分别为54.24%和55.9%。VEGF和Flt-1 mRNA的表达与生长方式、肿瘤浸润深度、血管浸润、淋巴结及远处转移之间存在显著相关性(P<0.01)。T3-T4期患者或有血管浸润、淋巴结及远处转移患者的平均肿瘤微血管密度(MVD)显著高于T1-T2期且无转移患者(P<0.01)。MVD值与VEGF和Flt-1 mRNA的表达水平相关(P<0.01)。mRNA表达阳性且平均MVD值≥54.9/mm2患者的平均生存时间和生存率显著低于mRNA表达阴性且平均MVD值<54.9/mm2的患者。
VEGF和Flt-1的表达可促进胃癌肿瘤血管生成,并有助于肿瘤侵袭和转移。VEGF和Flt-1可能作为胃癌生物学行为、预后及基因治疗靶点的有价值指标。